SQ-LIP-000007 · v1.5 (archived) · View current version →
Is lipedema associated with thyroid disease?
Also asked as
- Does having lipedema increase the chance of developing thyroid disorders?
- Is there a link between lipedema and thyroid conditions?
- lipedema thyroid disease association
- Are people with lipedema more likely to have problems with their thyroid?
- Current answer
- Lipedema is descriptively associated with elevated rates of thyroid disease, particularly hypothyroidism and chronic autoimmune thyroiditis, though this association has not been…
- Knowledge state
- Emerging · Evidence confidence: low (GRADE) · Stability: Evolving
- Evidence
- 5 supporting · 0 contradicting · 1 refining / context
- ⚠ none indexed yet — the registry may under-detect disconfirming evidence (a known limitation)
- Main limitation
- Whether the observed lipedema-thyroid co-occurrence reflects a true independent association or is confounded (e.g.
- Latest change
- This update added two more descriptive cross-sectional sources (a Spanish cohort of 1,803 patients and a Saudi Arabian study reporting 16% hypothyroidism)… · v1.5
- Knowledge freshness
- 75% recent · current evidence base
- Last updated
- 2026-05-31 · v1.5
Based on currently indexed evidence, lipedema is descriptively associated with elevated rates of thyroid disease, particularly hypothyroidism and chronic autoimmune thyroiditis, though this association has not been confirmed as independent. Multiple cross-sectional cohorts and surveys across diverse populations consistently report higher thyroid disorder prevalence in lipedema patients than general-population estimates or lymphedema controls: a German liposuction survey (n=209) found hypothyroidism in 35.9%; a large Spanish cohort (n=1803, moderate quality) identified thyroid disorders as a common comorbidity; an Italian cohort (n=360) reported elevated chronic autoimmune thyroiditis specifically; a Saudi Arabian cross-sectional study reported hypothyroidism in 16%; and a comparative cohort found thyroid disease in 24.4% of lipedema vs 14.89% of lymphedema patients. However, the single study that formally tested the association — a Brazilian cross-sectional screening study — found hypothyroidism common in crude terms (19.4%) but NOT an independent factor on multivariate analysis (p=0.141), suggesting the observed co-occurrence may reflect confounding (e.g. by obesity) rather than a true independent association. All supporting studies are observational (cross-sectional or retrospective), rated low-to-moderate quality, with largely unknown risk of bias, no randomized or prospective controlled designs, and — apart from the single Brazilian multivariate analysis — no adjustment for confounders such as BMI, sex, or healthcare-seeking behavior. The evidence is consistent in descriptive direction across multiple populations but remains preliminary, and the one study that formally tested independence did not confirm it.
A synthesis rendered from the currently indexed evidence — versioned, not a verdict.
⚙ AI consolidation: Claude Opus 4.8 · 2026-05-31 — evidence-bounded; the AI does not opine
This update added two more descriptive cross-sectional sources (a Spanish cohort of 1,803 patients and a Saudi Arabian study reporting 16% hypothyroidism), reinforcing the consistency of the descriptive association across additional populations without adding any adjusted analysis or changing the unconfirmed-independence conclusion.
Knowledge freshness = share of the 8 indexed evidence sources from the last 5 years (newest 2025, oldest 2019) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
supporting contradicting refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline. The hollow ring marks the first time this topic appears in the literature.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
Supporting claims
- SCR-LIP-000020 supporting
Thyroid disorders may be more frequent in lipedema than in lymphedema, with a cross-sectional cohort reporting thyroid disease in 24.4% of lipedema vs 14.89% of lymphedema patients.
Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study — Fiengo & Sbarbati (2025) - SCR-LIP-000134 supporting
In a survey of 209 German women with lipedema who underwent liposuction, hypothyroidism was present in 35.9% of participants, a frequency described as far beyond the average prevalence in the general German population.
New Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat — Bauer et al. (2019) · Disease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis — Ghods et al. (2020) - SCR-LIP-000135 supporting
In a cohort of 1803 lipedema patients in Spain, thyroid disorders were reported as a common comorbidity alongside other inflammatory and connective tissue conditions.
Clinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) · DOI:10.20944/preprints202510.1397.v1 - SCR-LIP-000136 supporting
In a cohort of 360 Italian women with lipedema, the prevalence of chronic autoimmune thyroiditis was higher compared to the general population.
Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History — Patton et al. (2024) - SCR-LIP-000245 supporting
In a cross-sectional study of patients diagnosed with lipedema in Saudi Arabia, hypothyroidism was reported as a comorbidity in 16% of patients, though no adjusted analysis of the lipedema-thyroid association was performed.
DOI:10.1097/gox.0000000000006173
Contradictory claims
- None indexed yet.
Refining / context
- SCR-LIP-000137 refines
In a Brazilian cross-sectional screening study, hypothyroidism was common in women with lipedema (crude prevalence 19.4%) but was NOT an independent factor associated with lipedema on multivariate analysis (p=0.141) — the raw co-occurrence may reflect confounding (e.g. by obesity) rather than a true independent association.
Lipedema prevalence and risk factors in Brazil — Amato et al. (2022)
Major uncertainty
Whether the observed lipedema-thyroid co-occurrence reflects a true independent association or is confounded (e.g. by obesity) remains unresolved: the only study to test independence (Brazilian multivariate analysis) did not confirm it, and no prospective, controlled, or adequately confounder-adjusted study exists to establish causality or direction.
Version history
- SQ-LIP-000007 · v1.5 — 2026-05-31 — This update added two more descriptive cross-sectional sources (a Spanish cohort of 1,803 patients and a Saudi Arabian study reporting 16% hypothyroidism), reinforcing the consistency of the descriptive association across additional populations without adding any adjusted analysis or changing the unconfirmed-independence conclusion. · view this version
- SQ-LIP-000007 · v1.4 — 2026-05-31 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000007 · v1.3 — 2026-05-31 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000007 · v1.2 — 2026-05-31 — This update added cross-national comparative data from Brazilian, Polish, and Dutch cohorts showing variable but consistently notable hypothyroidism prevalence rates in lipedema patients (19.4%, 31.6%, and 11.7%, respectively), reinforcing the cross-population consistency of the association while highlighting inter-cohort variability. · view this version
- SQ-LIP-000007 · v1.1 — 2026-05-31 — This update substantially strengthened the evidence base by adding three new cohorts (n=209 German, n=1803 Spanish, n=360 Italian) that consistently report elevated thyroid disorder prevalence—including specifically chronic autoimmune thyroiditis—in lipedema patients, upgrading two claims to moderate quality and broadening the finding beyond a single comparison cohort. · view this version
- SQ-LIP-000007 · v1.0 — 2026-05-30 — founding index (6 claims) · view this version
Key references
DOI:10.3390/jcm14207195 · DOI:10.1097/prs.0000000000006280 · DOI:10.1111/dth.14534 · DOI:10.3390/biomedicines13123049 · DOI:10.20944/preprints202510.1397.v1 · DOI:10.3390/ijms25031599 · DOI:10.1590/1677-5449.202101982 · DOI:10.1097/gox.0000000000006173